{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T20:23:47Z","timestamp":1773951827715,"version":"3.50.1"},"reference-count":30,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2014,8,18]],"date-time":"2014-08-18T00:00:00Z","timestamp":1408320000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Global Health Action"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.3402\/gha.v7.24593","type":"journal-article","created":{"date-parts":[[2014,8,18]],"date-time":"2014-08-18T08:37:43Z","timestamp":1408351063000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":7,"title":["Experiences in anti-tuberculosis treatment in patients with multiple previous treatments and its impact on drug resistant tuberculosis epidemics"],"prefix":"10.1080","volume":"7","author":[{"given":"Biao","family":"Xu","sequence":"first","affiliation":[{"name":"Department of EpidemiologySchool of Public Health, Fudan University, Shanghai, China;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of EpidemiologySchool of Public Health, Fudan University, Shanghai, China;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of EpidemiologySchool of Public Health, Fudan University, Shanghai, China;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of EpidemiologySchool of Public Health, Fudan University, Shanghai, China;"},{"name":"The Department of Tuberculosis Prevention and ControlMinistry of Health, Beijing, China;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weibing","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of EpidemiologySchool of Public Health, Fudan University, Shanghai, China;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinod K.","family":"Diwan","sequence":"additional","affiliation":[{"name":"School of Public HealthCentre for Global Health, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2014,8,18]]},"reference":[{"key":"e_1_3_4_2_1","volume-title":"Global tuberculosis control: WHO report 2011 (WHO\/HTM\/TB\/2011.16)","author":"WHO","year":"2011","unstructured":"WHO. Global tuberculosis control: WHO report 2011 (WHO\/HTM\/TB\/2011.16). 2011; Geneva: WHO."},{"key":"e_1_3_4_3_1","doi-asserted-by":"crossref","unstructured":"Zhao Y Xu S Wang L Chin DP Wang S Jiang G etal. National survey of drug-resistant tuberculosis in China. N Engl J Med. 2012; 366: 2161\u201370. [PubMed Abstract].","DOI":"10.1056\/NEJMoa1108789"},{"key":"e_1_3_4_4_1","first-page":"430","article-title":"Extensively drug-resistant tuberculosis (XDR-TB): recommendations for prevention and control","volume":"81","year":"2006","unstructured":"Extensively drug-resistant tuberculosis (XDR-TB): recommendations for prevention and control. Wkly Epidemiol Rec. 2006; 81: 430\u20132.","journal-title":"Wkly Epidemiol Rec"},{"key":"e_1_3_4_5_1","first-page":"301","article-title":"Centers for Disease Control and Prevention (CDC). Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs \u2013 worldwide, 2000\u20132004","volume":"55","year":"2006","unstructured":"Centers for Disease Control and Prevention (CDC). Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs \u2013 worldwide, 2000\u20132004. MMWR Morb Mortal Wkly Rep. 2006; 55: 301\u20135.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_4_6_1","doi-asserted-by":"crossref","unstructured":"Marahatta SB. Multi-drug resistant tuberculosis burden and risk factors: an update. Kathmandu Univ Med J (KUMJ). 2010; 8: 116\u201325. [PubMed Abstract].","DOI":"10.3126\/kumj.v8i1.3234"},{"key":"e_1_3_4_7_1","doi-asserted-by":"crossref","unstructured":"Dheda K Warren RM Zumla A Grobusch MP. Extensively drug-resistant tuberculosis: epidemiology and management challenges. Infect Dis Clin North Am. 2010; 24: 705\u201325. [PubMed Abstract].","DOI":"10.1016\/j.idc.2010.05.001"},{"key":"e_1_3_4_8_1","doi-asserted-by":"crossref","unstructured":"Nathanson E Lambregts-van Weezenbeek C Rich ML Gupta R Bayona J Blondal K etal. Multidrug-resistant tuberculosis management in resource-limited settings. Emerg Infect Dis. 2006; 12: 1389\u201397. [PubMed Abstract] [PubMed CentralFull Text].","DOI":"10.3201\/eid1209.051618"},{"key":"e_1_3_4_9_1","unstructured":"World Health Organization. Multidrug and extensively drug-resistant tuberculosis (M\/XDR-TB). 2010 global report on surveillance and response. 2010; Geneva Switzerland: World Health Organization."},{"key":"e_1_3_4_10_1","doi-asserted-by":"crossref","unstructured":"Luciani F Sisson SA Jiang H Francis AR Tanaka MM. The epidemiological fitness cost of drug resistance in Mycobacterium tuberculosis . Proc Natl Acad Sci USA. 2009; 106: 14711\u201315. [PubMed Abstract] [PubMed CentralFull Text].","DOI":"10.1073\/pnas.0902437106"},{"key":"e_1_3_4_11_1","doi-asserted-by":"crossref","unstructured":"Cha J Lee HY Lee KS Koh WJ Kwon OJ Yi CA etal. Radiological findings of extensively drug-resistant pulmonary tuberculosis in non-AIDS adults: comparisons with findings of multidrug-resistant and drug-sensitive tuberculosis. Korean J Radiol. 2009; 10: 207\u201316. [PubMed Abstract] [PubMed CentralFull Text].","DOI":"10.3348\/kjr.2009.10.3.207"},{"key":"e_1_3_4_12_1","doi-asserted-by":"crossref","unstructured":"Zhao P Li XJ Zhang SF Wang XS Liu CY. Social behaviour risk factors for drug resistant tuberculosis in mainland China: a meta-analysis. J Int Med Res. 2012; 40: 436\u201345. [PubMed Abstract].","DOI":"10.1177\/147323001204000205"},{"key":"e_1_3_4_13_1","doi-asserted-by":"crossref","unstructured":"Vilarica AS Gomes C Pina J. Comparative analysis of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis \u2013 epidemiology and predictive factors. Rev Port Pneumol. 2008; 14: 829\u201342. [PubMed Abstract].","DOI":"10.1016\/S2173-5115(08)70310-5"},{"key":"e_1_3_4_14_1","doi-asserted-by":"crossref","unstructured":"Xu W Lu W Zhou Y Zhu L Shen H Wang J. Adherence to anti-tuberculosis treatment among pulmonary tuberculosis patients: a qualitative and quantitative study. BMC Health Serv Res. 2009; 9: 169. [PubMed Abstract] [PubMed CentralFull Text].","DOI":"10.1186\/1472-6963-9-169"},{"key":"e_1_3_4_15_1","unstructured":"Sun Q Meng Q Yip W Yin X Li H. DOT in rural China: experience from a case study in Shandong Province China. Int J Tuberc Lung Dis. 2008; 12: 625\u201330. [PubMed Abstract]."},{"key":"e_1_3_4_16_1","doi-asserted-by":"crossref","unstructured":"Long Q Li Y Wang Y Yue Y Tang C Tang S etal. Barriers to accessing TB diagnosis for rural-to-urban migrants with chronic cough in Chongqing China: a mixed methods study. BMC Health Serv Res. 2008; 8: 202. [PubMed Abstract] [PubMed CentralFull Text].","DOI":"10.1186\/1472-6963-8-202"},{"key":"e_1_3_4_17_1","unstructured":"Wei X Liang X Liu F Walley JD Dong B. Decentralising tuberculosis services from county tuberculosis dispensaries to township hospitals in China: an intervention study. Int J Tuberc Lung Dis. 2008; 12: 538\u201347. [PubMed Abstract]."},{"key":"e_1_3_4_18_1","doi-asserted-by":"crossref","unstructured":"Yao S Huang WH van den Hof S Yang SM Wang XL Chen W etal. Treatment adherence among sputum smear-positive pulmonary tuberculosis patients in mountainous areas in China. BMC Health Serv Res. 2011; 11: 341. [PubMed Abstract] [PubMed CentralFull Text].","DOI":"10.1186\/1472-6963-11-341"},{"key":"e_1_3_4_19_1","doi-asserted-by":"crossref","unstructured":"Hu D Liu X Chen J Wang Y Wang T Zeng W etal. Direct observation and adherence to tuberculosis treatment in Chongqing China: a descriptive study. Health Policy Plan. 2008; 23: 43\u201355. [PubMed Abstract].","DOI":"10.1093\/heapol\/czm038"},{"key":"e_1_3_4_20_1","doi-asserted-by":"crossref","unstructured":"Fanning A. For tuberculosis elimination directly observed therapy short course (DOTS) is essential but not sufficient. Int J Circumpolar Health. 2011; 70: 106\u20138. [PubMed Abstract].","DOI":"10.3402\/ijch.v70i2.17804"},{"key":"e_1_3_4_21_1","doi-asserted-by":"crossref","unstructured":"Sharma SK Liu JJ. Progress of DOTS in global tuberculosis control. Lancet. 2006; 367: 951\u20132. [PubMed Abstract].","DOI":"10.1016\/S0140-6736(06)68391-8"},{"key":"e_1_3_4_22_1","doi-asserted-by":"crossref","unstructured":"Lew W Pai M Oxlade O Martin D Menzies D. Initial drug resistance and tuberculosis treatment outcomes: systematic review and meta-analysis. Ann Intern Med. 2008; 149: 123\u201334. [PubMed Abstract].","DOI":"10.7326\/0003-4819-149-2-200807150-00008"},{"key":"e_1_3_4_23_1","doi-asserted-by":"crossref","unstructured":"Bojorquez-Chapela I Backer CE Orejel I Lopez A Diaz-Quinonez A Hernandez-Serrato MI etal. Drug resistance in Mexico: results from the National Survey on Drug-Resistant Tuberculosis. Int J Tuberc Lung Dis. 2013; 17: 514\u201319. [PubMed Abstract].","DOI":"10.5588\/ijtld.12.0167"},{"key":"e_1_3_4_24_1","doi-asserted-by":"crossref","unstructured":"He GX Zhao YL Jiang GL Liu YH Xia H Wang SF etal. Prevalence of tuberculosis drug resistance in 10 provinces of China. BMC Infect Dis. 2008; 8: 166. [PubMed Abstract] [PubMed CentralFull Text].","DOI":"10.1186\/1471-2334-8-166"},{"key":"e_1_3_4_25_1","doi-asserted-by":"crossref","unstructured":"Ausina Ruiz V Fernandez-Rivas G Vilaplana Messeguer C. Selected culture and drug-susceptibility testing methods for drug-resistant Mycobacterium tuberculosis screening in resource-constrained settings. Expert Rev Mol Diagn. 2013; 13: 247\u20139. [PubMed Abstract].","DOI":"10.1586\/erm.13.10"},{"key":"e_1_3_4_26_1","doi-asserted-by":"crossref","unstructured":"Lawn SD Mwaba P Bates M Piatek A Alexander H Marais BJ etal. Advances in tuberculosis diagnostics: the Xpert MTB\/RIF assay and future prospects for a point-of-care test. Lancet Infect Dis. 2013; 13: 349\u201361. [PubMed Abstract].","DOI":"10.1016\/S1473-3099(13)70008-2"},{"key":"e_1_3_4_27_1","doi-asserted-by":"crossref","unstructured":"Falzon D Jaramillo E Schunemann HJ Arentz M Bauer M Bayona J etal. WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. Eur Respir J. 2011; 38: 516\u201328. [PubMed Abstract].","DOI":"10.1183\/09031936.00073611"},{"key":"e_1_3_4_28_1","unstructured":"He GX van den Hof S Borgdorff MW van der Werf MJ Cheng SM Hu YL etal. Availability of second-line drugs and anti-tuberculosis drug susceptibility testing in China: a situational analysis. Int J Tuberc Lung Dis. 2010; 14: 884\u20139. [PubMed Abstract]."},{"key":"e_1_3_4_29_1","first-page":"14","article-title":"China-Japan cooperation project on second-line tuberculosis drug resistance survey in Henan Province","volume":"26","author":"Zhang G","year":"2005","unstructured":"Zhang G, Du C, Kurasawa T, Ikeda X, Wang W, Shi R, etal. China-Japan cooperation project on second-line tuberculosis drug resistance survey in Henan Province. J Med Forum. 2005; 26: 14\u201316.","journal-title":"J Med Forum"},{"key":"e_1_3_4_30_1","unstructured":"Kam KM Yip CW. Surveillance of Mycobacterium tuberculosis susceptibility to second-line drugs in Hong Kong after the implementation of DOTS-plus 1995\u20132002. Int J Tuberc Lung Dis. 2004; 8: 760\u20136. [PubMed Abstract]."},{"key":"e_1_3_4_31_1","doi-asserted-by":"crossref","unstructured":"Hu Y Hoffner S Wu L Zhao Q Jiang W Xu B. Prevalence and genetic characterization of second-line drug-resistant and extensively drug-resistant Mycobacterium tuberculosis in Rural China. Antimicrob Agents Chemother. 2013; 57: 3857\u201363. [PubMed Abstract] [PubMed CentralFull Text].","DOI":"10.1128\/AAC.00102-13"}],"container-title":["Global Health Action"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.3402\/gha.v7.24593","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T11:52:12Z","timestamp":1706097132000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.3402\/gha.v7.24593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,18]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["10.3402\/gha.v7.24593"],"URL":"https:\/\/doi.org\/10.3402\/gha.v7.24593","relation":{},"ISSN":["1654-9716","1654-9880"],"issn-type":[{"value":"1654-9716","type":"print"},{"value":"1654-9880","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,18]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=zgha20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=zgha20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2014-04-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-07-02","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-08-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"24593"}}